41% would have made different benefit elections if they better understood the options GREENWOOD VILLAGE, Colo., Oct. 16, 2024 /PRNewswire/ — Over half of Americans (53%) report that cost is the primary driver for choosing benefits during open enrollment, and 35% of Millennials (27% of…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
A common drug that makes patients sleepy and less anxious before surgery is associated with an increased risk of heart damage when operations are performed at night, according to a study by researchers at the […]
The community will couple one-bedroom apartments with intensive services. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
BOULDER, Colo.–(BUSINESS WIRE)—- $CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) today announced positive top-line data from the Phase 3, open-label, multicenter, randomized TRITON3 trial demonstrating that Rubraca monotherapy treatment achieved the primary endpoint of significantly improved radiographic […]
Copyright © 2026 Biotech Networks
